Tower Research Capital LLC (Trc) Galmed Pharmaceuticals Ltd. Transaction History

Tower Research Capital LLC (Trc)

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.75 - $3.03 $3,176 - $5,499	-1,815 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.41 - $3.33 $1,383 - $1,911	574 Added 46.25%	1,815 $5,000
Q2 2021 Aug 16, 2021	SELL	$2.24 - $3.9 $2,972 - $5,175	-1,327 Reduced 51.67%	1,241 $4,000
Q1 2021 May 17, 2021	SELL	$3.19 - $5.4 $18,288 - $30,958	-5,733 Reduced 69.06%	2,568 $9,000
Q4 2020 Feb 16, 2021	SELL	$3.06 - $4.17 $5,281 - $7,197	-1,726 Reduced 17.21%	8,301 $26,000

Q3 2020 Nov 16, 2020	BUY	$3.46 - $5.69 $34,693 - $57,053	10,027 New	10,027 $35,000
Q2 2020 Aug 13, 2020	SELL	$3.22 - $6.08 $4,984 - $9,411	-1,548 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$3.3 - $6.84 $15,774 - $32,695	-4,780 Reduced 75.54%	1,548 $5,000
Q4 2019 Feb 07, 2020	BUY	$3.61 - $6.75 $22,844 - $42,714	6,328 New	6,328 $37,000
Q3 2019 Nov 05, 2019	SELL	$4.62 - $7.11 $24,056 - $37,021	-5,207 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$5.68 - $8.68 $26,275 - $40,153	4,626 Added 796.21%	5,207 $38,000
Q1 2019 May 14, 2019	BUY	$7.27 - $9.07 $3,940 - $4,915	542 Added 1389.74%	581 $5,000
Q4 2018 Feb 14, 2019	SELL	$6.59 - $14.47 $2,181 - $4,789	-331 Reduced 89.46%	39 $0
Q3 2018 Nov 13, 2018	BUY	$10.55 - $15.28 $3,903 - $5,653	370 New	370 $5,000

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $7.78M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.